Logo 2900 (Glipizide extended release 10 mg)

Pill imprint Logo 2900 has been identified as Glipizide extended release 10 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not a controlled substance under the Controlled Substance Act (CSA).

Glipizide extended release

Imprint:

Logo 2900

Strength:

10 mg

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Sulfonylureas

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Actavis

National Drug Code (NDC):

00228-2900

Inactive Ingredients:

acetyltributyl citrate
hydroxyethyl cellulose (140 cps at 5%)
hypromellose
hydroxypropyl cellulose
lactose monohydrate
sodium chloride
magnesium stearate
ferric oxide red
methacrylic acid - ethyl acrylate copolymer (1:1) type a
cellulose acetate
polyethylene glycol

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.